Shopping Cart 0
Cart Subtotal
USD 0

RedHill Biopharma Ltd (RDHL) - Financial and Strategic SWOT Analysis Review

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 125

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 250

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 375
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

RedHill Biopharma Ltd (RDHL)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

RedHill Biopharma Ltd (RedHill) is a biopharmaceutical company that develops and commercializes therapeutics in the areas of gastroenterology (GI) and cancer. The company's commercial product portfolio consists of Donnatal for IBS and acute enterocolitis; Esomeprazole Strontium Delayed-Release Capsules 49.3 mg for GERD and other GI conditions; and EnteraGam, a medical food intended for the dietary management. It sells these three specialty GI products in select US territories. RedHill is investigating pipeline candidates for the treatment of GI disorders and cancer that include helicobacter pylori infection, Crohn's disease, multiple sclerosis and pancreatic cancer among others. RedHill is headquartered in Tel Aviv, Israel.

RedHill Biopharma Ltd Key Recent Developments

May 08,2018: RedHill Biopharma Reports First Quarter 2018 Financial Results

Apr 09,2018: RedHill Biopharma Provides Semi-Annual Business Update

Feb 22,2018: RedHill Biopharma Provides Fourth Quarter and Full-Year 2017 Investor Update

Dec 05,2017: RedHill Biopharma Provides 2017 Year-End Business Update

Nov 13,2017: RedHill Biopharma Reports 2017 Third Quarter Financial Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Section 1-About the Company 6

RedHill Biopharma Ltd-Key Facts 6

RedHill Biopharma Ltd-Key Employees 7

RedHill Biopharma Ltd-Key Employee Biographies 8

RedHill Biopharma Ltd-Key Operational Employees 9

RedHill Biopharma Ltd-Major Products and Services 10

RedHill Biopharma Ltd-History 11

RedHill Biopharma Ltd-Locations And Subsidiaries 13

Head Office 13

Other Locations & Subsidiaries 13

Section 2-Company Analysis 14

Company Overview 14

RedHill Biopharma Ltd-Business Description 15

R&D Overview 15

RedHill Biopharma Ltd-Corporate Strategy 16

RedHill Biopharma Ltd-SWOT Analysis 17

SWOT Analysis-Overview 17

RedHill Biopharma Ltd-Strengths 17

RedHill Biopharma Ltd-Weaknesses 18

RedHill Biopharma Ltd-Opportunities 19

RedHill Biopharma Ltd-Threats 20

RedHill Biopharma Ltd-Key Competitors 21

Section 3-Company Financial Ratios 22

Financial Ratios-Capital Market Ratios 22

Financial Ratios-Annual Ratios 23

Performance Chart 25

Financial Performance 25

Financial Ratios-Interim Ratios 26

Financial Ratios-Ratio Charts 27

Section 4-Company's Lifesciences Financial Deals and Alliances 28

RedHill Biopharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 28

RedHill Biopharma Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 29

RedHill Biopharma Ltd, Recent Deals Summary 30

Section 5-Company's Recent Developments 31

May 08, 2018: RedHill Biopharma Reports First Quarter 2018 Financial Results 31

Apr 09, 2018: RedHill Biopharma Provides Semi-Annual Business Update 33

Feb 22, 2018: RedHill Biopharma Provides Fourth Quarter and Full-Year 2017 Investor Update 34

Dec 05, 2017: RedHill Biopharma Provides 2017 Year-End Business Update 36

Nov 13, 2017: RedHill Biopharma Reports 2017 Third Quarter Financial Results 37

Nov 06, 2017: RedHill Biopharma Announces EnteraGam Poster Presentation at the ISPOR 20th Annual European Congress 40

Aug 10, 2017: RedHill Biopharma Provides 2017 Semi-Annual Business Update 41

Jul 25, 2017: RedHill Biopharma Reports 2017 Second Quarter Financial Results 44

May 03, 2017: RedHill Biopharma Reports 2017 First Quarter Financial Results 46

Mar 29, 2017: RedHill Biopharma: Notice of Annual General Meeting of Shareholders 47

Section 6-Appendix 49

Methodology 49

Ratio Definitions 49

About GlobalData 53

Contact Us 53

Disclaimer 53


List Of Figure

List of Figures

RedHill Biopharma Ltd, Performance Chart (2013-2017) 25

RedHill Biopharma Ltd, Ratio Charts 27

RedHill Biopharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 28

RedHill Biopharma Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 29


List Of Table

List of Tables

RedHill Biopharma Ltd, Key Facts 6

RedHill Biopharma Ltd, Key Employees 7

RedHill Biopharma Ltd, Key Employee Biographies 8

RedHill Biopharma Ltd, Key Operational Employees 9

RedHill Biopharma Ltd, Major Products and Services 10

RedHill Biopharma Ltd, History 11

RedHill Biopharma Ltd, Subsidiaries 13

RedHill Biopharma Ltd, Key Competitors 21

RedHill Biopharma Ltd, Ratios based on current share price 22

RedHill Biopharma Ltd, Annual Ratios 23

RedHill Biopharma Ltd, Annual Ratios (Cont...1) 24

RedHill Biopharma Ltd, Interim Ratios 26

RedHill Biopharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 28

RedHill Biopharma Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 29

RedHill Biopharma Ltd, Recent Deals Summary 30

Currency Codes 49

Capital Market Ratios 49

Equity Ratios 50

Profitability Ratios 50

Cost Ratios 51

Liquidity Ratios 51

Leverage Ratios 52

Efficiency Ratios 52

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

RedHill Biopharma Ltd, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Companies

Unipharm Ltd

Therapix Biosciences Ltd

Nutrinia Ltd

Dexcel PT Israel Ltd

Adare Pharmaceuticals Inc